+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "G Protein Coupled Receptors"

From
From
G-Protein Coupled Receptors Market Report 2025 - Product Thumbnail Image

G-Protein Coupled Receptors Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Difficult-to-Express Proteins Market Report 2025 - Product Thumbnail Image

Difficult-to-Express Proteins Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
G-Protein Coupled Receptors Market 2025-2033 - Product Thumbnail Image

G-Protein Coupled Receptors Market 2025-2033

  • Report
  • March 2025
  • 141 Pages
  • Global
From
From
From
G-Protein Coupled Receptor (GPCR) Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

G-Protein Coupled Receptor (GPCR) Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
From
G-Protein Coupled Receptors Market Report and Forecast 2024-2032 - Product Thumbnail Image

G-Protein Coupled Receptors Market Report and Forecast 2024-2032

  • Report
  • December 2023
  • 199 Pages
  • Global
From
Proteomics - Technologies, Markets and Companies - Product Thumbnail Image

Proteomics - Technologies, Markets and Companies

  • Report
  • November 2021
  • 656 Pages
  • Global
From
Loading Indicator

G Protein Coupled Receptors (GPCRs) are a class of proteins that are involved in a wide range of physiological processes, including cell signaling, metabolism, and homeostasis. They are the most abundant type of membrane receptor in the human body, and are involved in the regulation of many cellular processes. GPCRs are the target of many drugs, and are the focus of much research in the field of proteomics. Proteomics is the study of the structure and function of proteins, and GPCRs are a major focus of proteomics research. Proteomics research has enabled the development of new drugs and therapies that target GPCRs, and has also enabled the development of new diagnostic tools for diseases that involve GPCRs. Companies in the GPCR market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more